ADMA

ADMA Biologics · USD

Market closed US (NYSE / Nasdaq) · 09:30–16:00 · Mon 17:08 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About ADMA Biologics

ADMA Biologics is a biopharmaceutical company that develops and manufactures vaccines and other healthcare products, operating within the Healthcare sector.

HealthcareBiotechnologyPharmaceuticals

Ticker	ADMA
Name	ADMA Biologics
Currency	USD
Sector	Healthcare

Reputation

😎

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

…

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BEARISH

57.14

RSI (14)i

8.07

SMA 20i

9.18

SMA 50i

14.40

SMA 200i

0.06%

1di

0.06%

1wi

-2.54%

1mi

3.55%

30d voli

20.40

52w highi

7.60

52w lowi

-60.49%

from highi

-0.34

MACDi

Downtrend (50d below 200d)MACD bullish crossover

Computed from 258 locally-stored price bars.

AI signals

HOLD 80% · long_term 2026-06-08 10:14

The stock has been in a consolidation phase with minor fluctuations around the 7.95-8.15 range, indicating indecision among traders and investors. The recent price action shows no clear breakout above or below this range, suggesting that current market conditions are not favoring either a significant bullish or bearish move. Given the lack of new positive news or catalysts in recent headlines, it is prudent to maintain a cautious stance until more definitive signals emerge.

qwen2.5:3b